These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 20422943)

  • 41. Calcium channel blockers: differences between subclasses.
    Frishman WH
    Am J Cardiovasc Drugs; 2007; 7 Suppl 1():17-23. PubMed ID: 19845073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enalapril. A reappraisal of its pharmacology and therapeutic use in hypertension.
    Todd PA; Goa KL
    Drugs; 1992 Mar; 43(3):346-81. PubMed ID: 1374319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lercanidipine-induced chylous ascites: Case report and literature review.
    Basualdo JE; Rosado IA; Morales MI; Fernández-Ros N; Huerta A; Alegre F; Landecho MF; Lucena JF
    J Clin Pharm Ther; 2017 Oct; 42(5):638-641. PubMed ID: 28485829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The pharmacological basis for the combination of calcium channel antagonists and angiotensin converting enzyme inhibitors in the treatment of hypertension.
    Osswald H; Mühlbauer B
    J Hypertens Suppl; 1995 Aug; 13(2):S21-8. PubMed ID: 8576784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antihypertensive effect of manidipine.
    Roca-Cusachs A; Triposkiadis F
    Drugs; 2005; 65 Suppl 2():11-9. PubMed ID: 16398058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [THE ROLE PLEIOTROPIC EFFECTS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE IN PERIOPERATIVE THERAPY OF ARTERIAL HYPERTENSION.].
    Melnik MV; Afonicheva II; Beloborodova AV
    Anesteziol Reanimatol; 2016 Sep; 61(5):395-398. PubMed ID: 29489111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Lerkanidipin: evolution of dihydropyridine calcium antagonists continues].
    Fomin VV; Svistunov AA
    Kardiologiia; 2012; 52(11):75-9. PubMed ID: 23237399
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Third generation calcium antagonist lercanidipine: the evidence base for clinical decision].
    Pogosova GV; Ausheva AK; Karpova AV; Salbieva AO
    Kardiologiia; 2014; 54(2):43-6. PubMed ID: 24888200
    [No Abstract]   [Full Text] [Related]  

  • 49. [Dihydropyridines for treatment of arterial hypertension].
    Bareza N; Gasser S; Toferer E; Scheer E; Pruthi D; Gasser R
    Pharm Unserer Zeit; 2005; 34(5):388-91. PubMed ID: 16180361
    [No Abstract]   [Full Text] [Related]  

  • 50. Watanidipine. AE 0047, Calbren, GJ 0956, Vatanidipine.
    Drugs R D; 2002; 3(5):331-6. PubMed ID: 12455154
    [No Abstract]   [Full Text] [Related]  

  • 51. Lercanidipine/enalapril combination in the management of obesity-related hypertension.
    Grassi G
    Integr Blood Press Control; 2016; 9():69-77. PubMed ID: 27175094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Dihydropyridines from the first to the fourth generation: better effects and safety].
    Aouam K; Berdeaux A
    Therapie; 2003; 58(4):333-9. PubMed ID: 14679672
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and tolerability of the fixed lercanidipine-enalapril combination in the treatment of patients with essential hypertension.
    Rump LC
    Arzneimittelforschung; 2010; 60(3):124-30. PubMed ID: 20422943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of fixed-dose combinations in the management of hypertension: focus on lercanidipine-enalapril.
    Chatzikyrkou C; Haller H; Menne J
    Expert Opin Pharmacother; 2009 Aug; 10(11):1833-40. PubMed ID: 19527194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of the fixed-dose combination lercanidipine-enalapril in renal protection.
    Egan CG; Pontremoli R
    J Nephrol; 2011; 24(4):428-37. PubMed ID: 21279953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fixed-combination therapies in hypertension management: focus on enalapril/lercanidipine.
    Tocci G; Palano F; Pagannone E; Chin D; Ferrucci A; Volpe M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):115-23. PubMed ID: 19210207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.